EBS
NYSE · Biotechnology
Emergent Biosolutions Inc
$7.22
-0.04 (-0.55%)
Analyst Consensus
Strong Buy
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+275.1% upside
Low Target
$18.81
Average Target
$27.08
High Target
$37.55
Current Price
$7.22
Current
$7.22
$7.22
Target
$27.08
$27.08
$18.81
$27.08 avg
$37.55
Scenario Analysis
Bear Case
$18.81
160.5%
Low target
Base Case
$27.08
+275.1%
Avg target
Bull Case
$37.55
+420.1%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$14.06
-48.6% from high
52-Week Low
$5.06
+42.7% from low
Target vs 52W High
$27.08
+92.6% vs high
Next Earnings Report
Aug 11, 2026
2d
until earnings
EPS Est: $0.11
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |